Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers

British Journal of Cancer

Volumn 89, Issue 5, 2003, Pages 899-906

  Vernimmen, D ^a   Gueders, M ^a   Pisvin, S ^a   Delvenne, P ^a   Winkler, R ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

AP 2 transcription factor; ERBB2 promoter; Human; Immunocytochemistry

Indexed keywords

MESSENGER RNA; PROTEIN P185; TRANSCRIPTION FACTOR AP 2; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; ERBB2 GENE; GENE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; UPREGULATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0141841783     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601200     Document Type: Article

References (47)

1. Anttila MA, Kellokoski JK, Moisio KI, Mitchell PJ, Saarikoski S, Syrjanen K, Kosma VM (2000) Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer 82: 1974-1983
2. Bates NP, Hurst HC (1997) Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland. J Mammary Gland Biol Neoplasia 2: 153-163
3. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13: 1701-1707
4. Bosher JM, Williams T, Hurst HC (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92: 744-747
5. Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW, Tainsky MA (1993) An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 13: 4174-4185
6. Child SJ, Miller MK, Geballe AP (1999) Cell type-dependent and -independent control of HER-2/neu translation. Int J Biochem Cell Biol 31: 201-213
7. Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM (1998) NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res 58: 5123-5129
8. De Potter CR, Quatacker J, Maertens G, Van Daele S, Pauwels C, Verhofstede C, Eechaute W, Rods H (1989) The subcellular localization of the neu protein in human normal and neoplastic cells. Int J Cancer 44: 969-974
9. DiGiovanna MP (1999) Clinical significance of HER-2/neu overexpression: Part I. Principles Practice Oncol 13: 1-10
10. Doherty JK, Bond CT, Hua W, Adelman JP, Clinton GM (1999a) An alternative HER-2/neu transcript of 8 kb has an extended 3'UTR and displays increased stability in SKOV-3 ovarian carcinoma cells. Gynecol Oncol 74: 408-415
11. Doherty JK, Bond CT, Jardim A, Adelman JP, Clinton GM (1999b) The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc Natl Acad Sci USA 96: 10869-10874
12. Eloranta JJ, Hurst HC (2002) Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem 277: 30798-30804
13. Esparis-Ogando A, Diaz-Rodriguez E, Pandiella A (1999) Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and phosphatidylinositol 3-kinase. Biochem J 344: 339-348
14. Fajac A, Benard J, Lhomme C, Rey A, Duvillard P, Rochard F, Bernaudin JF, Riou G (1995) c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int J Cancer 64: 146-151
15. Grooteclaes M, Pasleau F, Dijkmans H, Berzi P, Albert A, Winkler-Gol R (1994) The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Cancer Res 54: 4193-4199
16. Grooteclaes M, Vernimmen D, Plaza S, Pasleau F, Hodzic D, Winkler-Gol R (1999) A new cis element is involved in the HER2 gene overexpression in human breast cancer cells. Cancer Res 59: 2527-2531
17. Hollywood DP, Hurst HC (1993) A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J 12: 2369-2375
18. Kapitanovic S, Spaventi R, Poljak L, Kapitanovic M, Pavelic ZP, Gluckman JL, Spaventi S, Pavelic K (1994) High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detect Prev 18: 97-101
19. Karjalainen JM, Kellokoski JK, Mannermaa AJ, Kujala HE, Moisio KI, Mitchell PJ, Eskelinen MJ, Alhava EM, Kosma VM (2000) Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma. Br J Cancer 82: 2015-2021
20. King BL, Carter D, Foellmer HG, Kacinski BM (1992) Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines. Am J Pathol 140: 23-31
21. Klapper LN, Kirschbaum MH, Sela M, Yarden Y (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77: 25-79
22. Kornilova ES, Taverna D, Hoeck W, Hynes NE (1992) Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene 7: 511-519
23. Lipponen P, Aaltomaa S, Kellokoski J, Ala-Opas M, Kosma V (2000) Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation. Eur Urol 37: 573-578
24. Maniatis T, fritsch E, Sambrook J (1982) Molecular Cloning: a Laboratory Manual. New York: Cold Spring Harb Lab
25. Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski MX, DuBois RN (2001) Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 120: 1713-1719
26. Maurer CA, Friess H, Kretschmann B, Zimmermann A, Stauffer A, Baer HU, Korc M, Buchler MW (1998) Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 29: 771-777
27. Miller S, Suen TC, Sexton T, Hung MC (1994) Mechanisms of deregulated HER2/neu expression in breast cancer cell lines. Int J Oncol 4: 599-608
28. Molina MA, Saez R, Ramsey EE, Garcia-Barchino MJ, Rojo F, Evans AJ, Albanell J, Keenan EJ, Lluch A, Garcia-Conde J, Baselga J, Clinton GM (2002) NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer. Clin Cancer Res 8: 347-353
29. Morote J, de Torres I, Caceres C, Vallejo C, Schwartz Jr S, Reventos J (1999) Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastatsic prostate cancer. Int J Cancer 84: 421-425
30. Nakae S, Shimada E, Urakawa T (1993) Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma. J Surg Oncol 54: 246-251
31. Newman SP, Bates NP, Vernimmen D, Parker MG, Hurst HC (2000) Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene 19: 490-497
32. Nezu M, Sasaki H, Kuwahara Y, Ochiya T, Yamada Y, Sakamoto H, Tashiro H, Yamazaki M, Ikeuchi T, Saito Y, Terada M (1999) Identification of a novel promoter and exons of the c-ERBB-2 gene. Biochem Biophys Res Commun 258: 499-505
33. Pasleau F, Grooteclaes M, Gol-Winkler R (1993) Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Oncogene 8: 849-854
34. Pupa SM, Menard S, Morelli D, Pozzi B, De Palo G, Colnaghi MI (1993) The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. Oncogene 8: 2917-2923
35. Ropponen KM, Kellokoski JK, Pirinen RT, Moisio KI, Eskelinen MJ, Alhava EM, Kosma VM (2001) Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. J Clin Pathol 54: 533-538
36. Ross JS, Fletcher JA (1999) HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 112: S53-S67
37. Ross JS, Nazeer T, Church K, Amato C, Figge H, Rifkin MD, Fisher HA (1993) Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. Cancer 72: 3020-3028
38. Ruiz M, Troncoso P, Bruns C, Bar-Eli M (2001) Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Clin Cancer Res 7: 4086-4095
39. Schreiber E, Matthias P, Muller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419
40. Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, Rauscher III FJ, Thor AD, Benz CC (2000) Ets regulation of the erbB2 promoter. Oncogene 19: 6490-6502
41. Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee J, Keller GA, Li WL, Fendly BM et al. (1993) A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol 13: 2247-2257
42. Siegel PM, Ryan ED, Cardiff RD, Muller WJ (1999) Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 18: 2149-2164
43. Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M (2000) Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst 92: 1918-1925
44. Vernimmen D, Begon D, Salvador C, Gofflot S, Grooteclaes M, Winkler R (2003) Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem J 370: 323-329
45. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Kunz J, Beger HG, Korc M (1993) Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol 24: 1127-1134
46. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137
47. Zabrecky JR, Lain T, McKenzie SJ, Carney W (1991) The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem 266: 1716-1720